
|Videos|January 16, 2023
Dr. Ravi highlights ongoing trials of PSMA-targeted agents in prostate cancer
Author(s)Urology Times staff
Advertisement
Praful Ravi, MB, BChir, MRCP,discusses trials exploring PSMA-targeted therapy at earlier disease stages and in combination regimens in patients with prostate cancer. Ravi is a medical oncologist at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute and an instructor in medicine at Harvard Medical School.
Advertisement
Latest CME
Advertisement
Advertisement











